United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
alliance healthcare (distribution) ltd - ursodeoxycholic acid - oral tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
viatris uk healthcare ltd - ursodeoxycholic acid - oral tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
waymade healthcare plc - ursodeoxycholic acid - oral tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
galen ltd - ursodeoxycholic acid - oral tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
mawdsley-brooks & company ltd - ursodeoxycholic acid - oral tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 150mg tablets
teva uk ltd - ursodeoxycholic acid - oral tablet - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ursodeoxycholic acid 250mg capsules
advanz pharma - ursodeoxycholic acid - oral capsule - 250mg
Ireland -
English -
HPRA (Health Products Regulatory Authority)
ursodeoxycholic acid 150 milligram tablets
teva b.v. - ursodeoxycholic acid - tablets - 150 milligram - bile acid preparations
Israel -
English -
Ministry of Health
chenodeoxycholic acid leadiant
mbi pharma ltd., israel - chenodeoxycholic acid - hard capsule - chenodeoxycholic acid 250 mg - chenodeoxycholic acid - the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
urso ursodeoxycholic acid 250mg/5ml oral liquid bottle
dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 50 mg/ml - oral liquid, suspension - excipient ingredients: benzoic acid; glycerol; citric acid; sodium chloride; purified water; sodium citrate dihydrate; propylene glycol; xylitol; sodium cyclamate; microcrystalline cellulose; carmellose sodium; flavour - treatment of chronic cholestatic liver diseases.